Chris Moose is a Partner in IBM's Healthcare and Life Sciences Consulting Organization where he advises companies on government policy, emerging technologies and funding mechanisms that will transform healthcare globally. He also develops and presents IBM’s point of view on HealthTech to Government and National Media audiences. His current focus areas include reducing illegitimate medicines, the Drug Supply Chain Security Act (DSCSA), Government actions on Healthcare Resiliency, improving LMIC healthcare supply chains and developing healthcare supply chain platforms.
